CD8A and neoplasm: For cancer vaccines to work, tumor antigens need to be delivered to dendritic cells (DCs) which in turn can process and present antigen-derived peptides via MHC class I and II molecules to naïve CD8+ and CD4+ T-cells respectively, and activate these T-cells to proliferate [2,11,20,21].